Blood Pressure

Cardiovascular disease (CVD) is the main cause of death for females, and elevated blood pressure is the leading risk factor for the development of CVD in females. Moreover, CVD is a major cause of illness and disability affecting women’s quality of life and causing high healthcare costs.

Gaps in knowledge and understanding regarding the risk of hypertension and CVD in women often lead to health misconceptions and hence to poor screening, insufficient implementation of preventive measures, and inadequate global management. The need to develop more evidence-based research on women’s health is now well recognized with the argument that greater attention to gender- and sex-related factors in disease-specific research areas should be globally beneficial for women as well as for health systems.

The scope of this Article Collection is to improve our current understanding of sex-related disease mechanisms and personalized methods and actions towards better detection, prevention, and management of hypertension-mediated cardiovascular risk in women, in the effort to help the field move forward. Authors are encouraged to provide up-to-date reviews and original scientific papers focused on both basic and clinical studies. Potential topics include, but are not limited to: epidemiological studies, mechanisms underlying hypertension and cardiovascular disease in women, hypertension disorders in pregnancy, and sex and gender aspects in hypertension management.

Please see this page for information about the journal's article publishing charges. Please follow this link for information about Taylor & Francis's open access memberships and agreements.

Jana Brguljan-Hitij, MD, PhD, FESC is Head of the Hypertension Department at the University Medical Centre in Ljubljana since 2016. She is also an Assistant Professor and has been lecturing at the Medical University of Ljubljana since 2006. She specialized in Internal Medicine and Cardiology and Vascular Medicine at the University Medical Centre in Ljubljana and earned in collaboration her master degree and PhD at the Catholic University of Leuven. Her current focus in hypertension research is women’s health and sex differences in hypertension. She confirmed the importance of ambulatory blood pressure monitoring in high-normal blood pressure-specific population groups. She was president of the Slovenian Hypertension Society and is an active member of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC), responsible for the ESH summer school organization, serves as an executive member of the Editorial Board for the Journal of Hypertension, and contributed to the 2018 and 2023 ESH hypertension guidelines.

Professor Krzysztof Narkiewicz is the Head of the Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland. His research has been focused on prevention and treatment of cardiometabolic diseases including hypertension, diabetes, coronary artery disease, congestive heart failure, and obstructive sleep apnea. He has published over 520 full-text publications (>39,000 citations; h-index: 64). He was the President of the Scientific Council of the European Society of Hypertension (2009-2011). He was a member of the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), preparing the 2007, 2013, and 2018 Guidelines for the Management of Arterial Hypertension; he also contributed to the 2023 ESH hypertension guidelines.

Prof. Brguljan-Hitij and Prof. Narkiewicz declare no conflict of interest regarding this work. 

Instructions for AuthorsSubmit an Article